These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 25381895)

  • 41. Neuroprotective Potential of Novel Multi-Targeted Isoalloxazine Derivatives in Rodent Models of Alzheimer's Disease Through Activation of Canonical Wnt/β-Catenin Signalling Pathway.
    Machhi J; Sinha A; Patel P; Kanhed AM; Upadhyay P; Tripathi A; Parikh ZS; Chruvattil R; Pillai PP; Gupta S; Patel K; Giridhar R; Yadav MR
    Neurotox Res; 2016 May; 29(4):495-513. PubMed ID: 26797524
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Developing predictive CSF biomarkers-a challenge critical to success in Alzheimer's disease and neuropsychiatric translational medicine.
    Flood DG; Marek GJ; Williams M
    Biochem Pharmacol; 2011 Jun; 81(12):1422-34. PubMed ID: 21295552
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 5-Lipoxygenase (ALOX5) and FLAP (ALOX5AP) gene polymorphisms as factors in vascular pathology and Alzheimer's disease.
    Manev H; Manev R
    Med Hypotheses; 2006; 66(3):501-3. PubMed ID: 16278051
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Animal models of Alzheimer's disease: an understanding of pathology and therapeutic avenues.
    Obulesu M; Rao DM
    Int J Neurosci; 2010 Aug; 120(8):531-7. PubMed ID: 20615056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Emerging concepts in Alzheimer's disease.
    Vinters HV
    Annu Rev Pathol; 2015; 10():291-319. PubMed ID: 25387055
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amyloid Beta1-42 and the Phoshorylated Tau Threonine 231 in Brains of Aged Cynomolgus Monkeys (Macaca fascicularis).
    Darusman HS; Gjedde A; Sajuthi D; Schapiro SJ; Kalliokoski O; Kristianingrum YP; Handaryani E; Hau J
    Front Aging Neurosci; 2014; 6():313. PubMed ID: 25426069
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Physiological functions of presenilins; beyond γ-secretase.
    Stiller I; Lizák B; Bánhegyi G
    Curr Pharm Biotechnol; 2014; 15(11):1019-25. PubMed ID: 25420727
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tau deletion impairs intracellular β-amyloid-42 clearance and leads to more extracellular plaque deposition in gene transfer models.
    Lonskaya I; Hebron M; Chen W; Schachter J; Moussa C
    Mol Neurodegener; 2014 Nov; 9():46. PubMed ID: 25384392
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Small liposomes accelerate the fibrillation of amyloid β (1-40).
    Terakawa MS; Yagi H; Adachi M; Lee YH; Goto Y
    J Biol Chem; 2015 Jan; 290(2):815-26. PubMed ID: 25406316
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cerebral circulation: function and dysfunction in Alzheimer's disease.
    Hamel E
    J Cardiovasc Pharmacol; 2015 Apr; 65(4):317-24. PubMed ID: 25384195
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Binding Receptors of Aβ: an Alternative Therapeutic Target for Alzheimer's Disease.
    Xia M; Cheng X; Yi R; Gao D; Xiong J
    Mol Neurobiol; 2016 Jan; 53(1):455-471. PubMed ID: 25465238
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aβ42 oligomers selectively disrupt neuronal calcium release.
    Lazzari C; Kipanyula MJ; Agostini M; Pozzan T; Fasolato C
    Neurobiol Aging; 2015 Feb; 36(2):877-85. PubMed ID: 25453559
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of active Aβ immunotherapy on neurons in human Alzheimer's disease.
    Paquet C; Amin J; Mouton-Liger F; Nasser M; Love S; Gray F; Pickering RM; Nicoll JA; Holmes C; Hugon J; Boche D
    J Pathol; 2015 Apr; 235(5):721-30. PubMed ID: 25430817
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Capping of aβ42 oligomers by small molecule inhibitors.
    Fu Z; Aucoin D; Ahmed M; Ziliox M; Van Nostrand WE; Smith SO
    Biochemistry; 2014 Dec; 53(50):7893-903. PubMed ID: 25422864
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DHA-PC and PSD-95 decrease after loss of synaptophysin and before neuronal loss in patients with Alzheimer's disease.
    Yuki D; Sugiura Y; Zaima N; Akatsu H; Takei S; Yao I; Maesako M; Kinoshita A; Yamamoto T; Kon R; Sugiyama K; Setou M
    Sci Rep; 2014 Nov; 4():7130. PubMed ID: 25410733
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Overexpression of mutant amyloid-β protein precursor and presenilin 1 modulates enteric nervous system.
    Puig KL; Lutz BM; Urquhart SA; Rebel AA; Zhou X; Manocha GD; Sens M; Tuteja AK; Foster NL; Combs CK
    J Alzheimers Dis; 2015; 44(4):1263-78. PubMed ID: 25408221
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Invited review: Prion-like transmission and spreading of tau pathology.
    Clavaguera F; Hench J; Goedert M; Tolnay M
    Neuropathol Appl Neurobiol; 2015 Feb; 41(1):47-58. PubMed ID: 25399729
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structure and mechanism of action of tau aggregation inhibitors.
    Cisek K; Cooper GL; Huseby CJ; Kuret J
    Curr Alzheimer Res; 2014; 11(10):918-27. PubMed ID: 25387336
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Laser capture microdissection of fluorescently labeled amyloid plaques from Alzheimer's disease brain tissue for mass spectrometric analysis.
    Nijholt DA; Stingl C; Luider TM
    Methods Mol Biol; 2015; 1243():165-73. PubMed ID: 25384745
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diarylethene based fluorescent switchable probes for the detection of amyloid-β pathology in Alzheimer's disease.
    Lv G; Cui B; Lan H; Wen Y; Sun A; Yi T
    Chem Commun (Camb); 2015 Jan; 51(1):125-8. PubMed ID: 25384304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.